comparemela.com
Home
Live Updates
Ankylosing Spondylitis Disease Activity - Breaking News
Pages:
Latest Breaking News On - Ankylosing spondylitis disease activity - Page 1 : comparemela.com
Upadacitinib impactful vs placebo in psoriatic arthritis with axial involvement
Patients with psoriatic arthritis and axial involvement experienced greater improvement when treated with upadacitinib 15 mg compared with placebo and adalimumab, according to data published in Arthritis Research & Therapy.
Nordrhein westfalen
University bochum
Arthritis research therapy
Arthritis research
Ruhr university bochum
Ankylosing spondylitis disease activity
Retention High With Biosimilar-to-Biosimilar Switch for Arthritis
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory arthritis.
United states
Jonathan kay
Hafsah nabi
Merete lund hetland
University of massachusetts
European medicines agency
Copenhagen center
American college of rheumatology
Arthritis research
American college
Clinical disease activity index
Ankylosing spondylitis disease activity
Biologic therapy
Biosimilar drugs
Follow on biologics
Psoriatic arthritis
vimarsana © 2020. All Rights Reserved.